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Abstract
Background: Recently moderate-virulence classical swine fever virus (CSFV) strains have been proven capable of
generating postnatal persistent infection (PI), defined by the maintenance of viremia and the inability to generate
CSFV-specific immune responses in animals. These animals also showed a type I interferon blockade in the absence
of clinical signs. In this study, we assessed the infection generated in 7-week-old CSFV PI wild boars after infection
with the African swine fever virus (ASFV). The wild boars were divided in two groups and were infected with ASFV.
Group A comprised boars who were CSFV PI in a subclinical form and Group B comprised pestivirus-free wild boars.
Some relevant parameters related to CSFV replication and the immune response of CSFV PI animals were studied.
Additionally, serum soluble factors such as IFN-α, TNF-α, IL-6, IL-10, IFN-γ and sCD163 were analysed before and
after ASFV infection to assess their role in disease progression.
Results: After ASFV infection, only the CSFV PI wild boars showed progressive acute haemorrhagic disease; however,
the survival rates following ASFV infection was similar in both experimental groups. Notwithstanding, the CSFV RNA
load of CSFV PI animals remained unaltered over the study; likewise, the ASFV DNA load detected after infection was
similar between groups. Interestingly, systemic type I FN-α and IL-10 levels in sera were almost undetectable in CSFV PI
animals, yet detectable in Group B, while detectable levels of IFN-γ were found in both groups. Finally, the flow cytometry
analysis showed an increase in myelomonocytic cells (CD172a+) and a decrease in CD4+ T cells in the PBMCs from CSFV
PI animals after ASFV infection.
Conclusions: Our results showed that the immune response plays a role in the progression of disease in CSFV subclinically
infected wild boars after ASFV infection, and the immune response comprised the systemic type I interferon blockade.
ASFV does not produce any interference with CSFV replication, or vice versa. ASFV infection could be a trigger factor for the
disease progression in CSFV PI animals, as their survival after ASFV was similar to that of the pestivirus-free ASFV-infected
group. This fact suggests a high resistance in CSFV PI animals even against a virus like ASFV; this may mean that there are
relevant implications for CSF control in endemic countries. The diagnosis of ASFV and CSFV co-infection in endemic
countries cannot be ruled out and need to be studied in greater depth.
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Background
African swine fever (ASF) and Classical swine fever (CSF)
are highly contagious viral diseases of domestic pigs, wild
boars and feral pigs [1, 2]. Because of their high socioeco-
nomic impact, both diseases must be reported to the
World Organisation for Animal Health (OIE).
ASF is caused by the large DNA virus African swine
fever virus (ASFV), currently the only member of the
Asfarviridae family [3]. ASFV encodes between 150 and
167 proteins, a number of which have been shown to
modulate host immune responses [1, 4]. Since 2007, a
highly virulent ASFV has spread from Sub-Saharan Africa
to Eastern Europe being detected in Russia, Armenia,
Azerbaijan, Estonia, Ukraine and Lithuania, among other
places [5]. Direct contact between infected wild boars and
domestic pigs has played a relevant role in the spread of
the disease in the Caucasus region and the Russian Feder-
ation [5–8]. CSF remains endemic in areas of Asia, Eur-
ope, Central and South America and parts of Africa. The
disease is caused by Classical swine fever virus (CSFV)
which belongs to the Pestivirus genus within the Flaviviri-
dae family [9]. CSFV is composed of a lipid envelope, a
capsid and a single plus-strand RNA genome carrying a
single, large open reading frame (ORF) flanked by two un-
translated regions (UTRs) [10].
Both ASFV and CSFV share a tropism for immune system
cells, mainly those that are derived from the monocyte-
macrophage lineage, which are central in orchestrating
innate and adaptive immune responses [1, 11, 12]. It is as-
sumed that the infection of these cells plays an important
role in virus replication and pathogenesis by exploiting their
migratory ability, which promotes viral spread and persist-
ence in the host for both ASFV and CSFV.
Type I IFN-α has beneficial effects for viral infections be-
cause it restricts viral dissemination, although it can promote
immunopathological events when released at high levels
over a longer duration [13]. CSFV induces a potent IFN-α
response, which is detected in the serum of CSFV acute-
infected pigs. This response has been hypothesised to be re-
lated to disease severity rather than to protective immune
responses [13, 14]. Likewise, previous studies have demon-
strated the increase in type I IFN-α response after infection
with ASFV virulent strains ([15–17]). In addition, macro-
phages, the main target cells for ASFV replication, produce
a range of inflammatory mediators, including chemokines
that play an important role in the disease’s progression [18].
Depending on many factors, including the nature of the viral
strain and the age, breed and immune system of the host,
varying degrees of disease severity can be observed, ranging
from acute to subclinical or chronic forms in infections
caused by both viruses [1, 4, 17, 19, 20]. In addition, the cir-
culation of CSFV strains of low and/or moderate virulence
has been associated with the maintenance of the virus in the
field, generating unapparent forms of CSF [21–23].
Recently, it was proven that CSFV can generate postna-
tal persistence by infecting both newborn piglets and wild
boars with either low- and/or moderate-virulence strains,
respectively [24, 25]. During the 6 weeks after postnatal
infection, most of the infected animals remained clinically
healthy, despite persistently high virus titres in the blood,
organs and body secretions. These animals were unable to
mount any detectable CSFV-specific humoral or cellular
immune responses [24, 25].
The superinfection exclusion (SIE) phenomenon is de-
fined as the ability of a primary virus infection to interfere
with a secondary infection caused by the same or a closely
related virus [26–28]. In this regard, CSVF PI wild boars
were protected from superinfection by the virulent CSFV
Margarita strain, showing efficient suppression of super-
infection in animals, especially in the absence of IFN-α,
which might be associated with the lack of innate immune
mechanisms [28]. Thus, considering the drastic effect of
ASFV on the swine immune system, in the present study,
we assessed the infection generated after African swine
fever virus (ASFV) inoculation in CSFV PI wild boars. For
this purpose, apparently healthy, CSFV postnatal PI wild
boars (7-week-old) [24] were inoculated with a highly
virulent ASFV strain. Some relevant parameters related to
CSFV and ASFV replication and immune response were
studied. Additionally, serum soluble factors including
IFN-α, TNF-α, IL-6, IL-10, IFN-γ and sCD163 were ana-
lysed before and after ASFV infection to assess their role
in the progression of disease in the CSFV PI animals.
Additionally, virological and immunological parame-




PK-15 cells (ATCC CCL 33) were cultured in Dulbecco’s
Modified Eagle Medium (DMEM), supplemented with
10% foetal bovine serum (FBS), pestivirus-free, at 37 °C
in 5% CO2. The cells were infected with CSFV 0.1
TCID50/cell in 2% FBS, and the virus was harvested 48 h
later. Peroxidase-linked assay (PLA) [29] was used for
CSFV titration following the statistical methods
described by Reed and Muench [30].
The CSFV Catalonia 01 (Cat01) strain used in this study
was isolated from the Spanish CSF epizootic in 2000–
2001 [31]. This isolate belongs to the CSFV 2.3 genogroup
[22]. The course of infection from this strain was found to
be mild [31, 32]. Finally, the moderately virulent E75
ASFV strain was used [33]. This strain was isolated in
1975 in Spain and propagated in pig leucocytes [17].
Experimental design
Two groups of three wild boars each (A and B), 7 weeks
old with 6 kg average weight were used [28]. These
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animals were acquired from Gestión Cinegética Integral
SL farm (Segovia, Spain).
Group A, wild boars 1 to 3, were postnatally CSFV PI
animals; they were intranasally infected in the first 24 h
after birth with 2.5 ml of 104TCID50/ml of the CSFV
Cat01 strain [24]. These wild boars remained apparently
healthy at 7 weeks old, but were viraemic and lacked
CSFV-specific cellular and humoral responses [24], similar
to CSFV PI piglets that were infected postnatally [25].
The second group (Group B, animals 4 to 6), housed
in an independent isolation unit at the BSL-3 facility of
CReSA, (animals 4 to 6), was used as control; these ani-
mals tested pestivirus-free throughout the experiment.
All the wild boars were fed with a conventional piglet
starter diet and pellets until the end of the trial (Startrite
100, Kwikstart and Prestarter; SCA Iberica S.A., Zara-
goza, Spain) and were handled according to previous
studies conducted in CReSA [24, 34]. After a 5-day accli-
mation period, all the animals were experimentally in-
fected by intramuscular (i.m.) injection in the neck with
a dose of 104 TCID50 ASFV E75 strain. In previous stud-
ies, this viral dose caused acute ASF and often induced
death within a week post-infection [17]. Sera and nasal
and rectal swabs were collected at 0, 3, 5, 7 and 10 days
post infection (dpi). Blood samples for the isolation of
PBMCs were collected in EDTA tubes at 0 dpi and at
the time of euthanasia (10 dpi).
A trained veterinarian recorded the clinical signs daily
in a blinded manner [35]. The clinical signs compatible
with CSFV and after ASFV infection were previously de-
scribed ([17, 31, 36–38]). Moreover, the clinical statuses
registered in both experimental groups were scored from
0 to 6 as follows: 0: no signs; 1: mild pyrexia; 2: pyrexia
plus mild clinical signs; 3: mild-to-moderate clinical
signs; 4: moderate clinical signs; 5: moderate-to-severe
clinical signs and 6: death. For ethical reasons, the ani-
mals were euthanized when the clinical score reached 5
or developed any of the following symptoms: fall of the
hindquarters, inability to drink or feed, prostration or
moderate nervous disorders. After euthanasia, an ex-
haustive necropsy was conducted, in which the presence
of pathological findings in different organs was evaluated
and tissues (spleen, lung and tonsil) were obtained. Eu-
thanasia was performed according to European Directive
2010/63/EU, using a pentobarbital overdose of 60–
100 mg/kg administered via the anterior vena cava. Ani-
mal care and procedures were in accordance with the
guidelines of the Good Experimental Practices (GEP),
under the supervision of the Ethical and Animal Welfare
Committee of the Autonomous University of Barcelona
(UAB), and they were approved under number 8804, ac-
cording to existing national and European regulations.
Additionally, the biosafety level of the viruses used in
this study was stated as biosecurity level 3, as approved
by the Biosafety Committee of the UAB, with registra-
tion assignment AR-296-15.
Detection of CSFV RNA
CSFV RNA was extracted from sera, nasal and rectal
swabs, and tonsil, spleen and lung tissues using the
NucleoSpin RNA isolation kit (Macherey-Nagel), ac-
cording to the manufacturer’s instructions. The presence
of CSFV RNA was analysed by a CSFV qRT-PCR [39].
Positive results were considered for threshold cycle
values (Ct) equal to or less than 42, when fluorescence is
no longer detected. Samples in which fluorescence was
undetectable were considered negative.
Detection of ASFV DNA
ASFV DNA was extracted from sera, nasal and rectal
swabs and tissue samples (tonsil, spleen and lung) using
the NucleoSpin blood kit (Macherey-Nagel, Düren,
Germany) according to the manufacturer’s recommenda-
tions. The presence of viral DNA was analysed by ASFV
qRT-PCR technique using a Universal Probe Library
[40]. Positive results were considered for threshold cycle
values (Ct) equal to or less than 40, when fluorescence is
no longer detected. Samples in which fluorescence was
undetectable were considered negative.
Specific CSFV and ASFV antibodies detection
For CSFV-specific antibody detection, sera from 0 dpi, 7
dpi and 10 dpi were tested with neutralisation
peroxidase-linked assay (NPLA) [41], and the titres were
expressed as the reciprocal dilution of serum that neu-
tralised 100 TCID50 of the Cat01 strain in 50% of the
culture replicates. The detection of CSFV E2-specific
antibodies was performed using a commercial ELISA kit
(HerdChek CSFV Ab, IDEXX) following the manufac-
turer’s recommendations. The samples were considered
positive when the blocking percentage was ≥40%. For
ASFV-specific antibody detection, a blocking ELISA
assay technique was conducted using a commercial
ELISA kit (INGEZIM PPA Compac, Ingenasa) following
the manufacturer’s recommendations. This ELISA test is
validated by the European Union Reference Laboratory
for ASF (EURL-ASF, CISA-INIA, Spain).
ELISA detection of serum soluble factors
Sera collected at days 0, 7 and 10 dpi were analysed for the
detection of several serum soluble factors. A house-ELISA
was used to evaluate the serum IFN-α levels. Anti-IFN-α
monoclonal antibodies (K9 and K17) and IFN-α recombin-
ant protein (PBL Biomedical Laboratories, Piscataway, New
Jersey, USA) were employed in the ELISA assay using a
previously described protocol [14, 25, 42]. On the other
hand, commercial ELISA tests were used for the detection
of tumour necrosis factor-α (TNF-α) (TNF alpha ELISA
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Kit, Porcine, Life Technology), interleukin-10 (IL-10) (IL-10
ELISA Kit, Porcine, Life Technology), IFN-γ (IFN-γ ELISA
Kit, Porcine, Life Technology) and interleuking-6 (IL-6)
(IL-6 ELISA Kit, Porcine, Life Technology). The results
were expressed as units per millilitre (U/ml) for IFN-α. For
IFN-γ, IL-6, TNF- α and IL-10, the results were expressed
in pg/ml. Finally, soluble CD-163 (sCD163) was quantified
by a formerly described ELISA using lysates from CD-
163-transfected Chinese hamster ovary (CHO) cells as
standard [43].
PBMC collection and phenotype analysis
To address the effect of ASFV infection on the PBMC pop-
ulations in both experimental groups, a comparative study
of the expression of different porcine surface markers was
carried out by flow cytometry, using cells collected before
and after ASFV infection (end-point lifetime after ASFV in-
fection). PBMCs were separated from whole blood by
density-gradient centrifugation with Histopaque 1077
(Sigma). The number and viability of the PBMCs were de-
termined by staining with Trypan Blue [36]. To phenotype
these cells, flow cytometry was performed using the corre-
sponding monoclonal antibody (mAbs). The mAbs for por-
cine CD4 (74–12-4, IgG2b) Alexa Fluor 647 conjugate (BD
Pharmingen) and CD8-α (76–2-11, IgG2a) FITC-labelled
(BD Pharmingen) were used. Further, anti-CD172a mAb
(BA1C11, IgG1) produced in our laboratory was used in in-
direct labelling, with goat anti-mouse IgG Alexa Fluor 647
conjugated (Jackson ImmunoResearch) as a secondary anti-
body. The staining protocols were performed as previously
described [17, 25, 42]. Finally, the cells were analysed by flow
cytometry, using a FACSCalibur (Becton Dickinson
FACSAria I) (Becton Dickinson, San Jose, California, USA),
and the positive percentages were analysed by FACSDiva
software, version 6.1.2 [25, 42].
Statistical analysis
All statistical analyses were performed using SPSS software,
version 15.0 (SPSS Inc., Chicago, Illinois, USA). The signifi-
cance level (α) was set at P < 0.05. Throughout the trial, a
non-parametric test (Mann-Whitney) was chosen to com-
pare values obtained from the clinical and virological pa-
rameters, PBMC phenotype and soluble factors parameters
between Groups A and B. This non-parametric analysis
was chosen due to the non-normality pattern observed for
the studied parameters and the small number of animals
used in each experimental group. Finally, a survival analysis
was carried out to test differences in survival throughout
the trial between Groups A and B.
Results
Clinical signs developed after E75 ASFV infection
After the E75-ASFV infection, one of the CSFV PI wild
boars (CSFV-ASFV infected) from Group A showed mild
clinical signs from 1 dpi to 3 dpi, consisting of mild pyr-
exia (40 °C - 40.5 °C) and mild apathy. No clinical signs
were recorded in the pestivirus-free-ASFV infected wild
boars (Group B) within this period; therefore, from 1 dpi
to 3 dpi no statistical significant differences were found
between both experimental groups (Fig. 1a–c). At 4 dpi,
the three CSFV-ASFV infected animals from Group A
presented mild apathy. Animal number 2 showed evi-
dence of cyanosis and petechial haemorrhages in the ears
and abdomen at five dpi; it suddenly died at 6 dpi. The
rest of the infected wild boars from Group A showed signs
of severe apathy, semi-prostration, cyanosis and haemor-
rhages in the skin, dyspnoea and tremors, for which reason
they were euthanized at 7 dpi, reaching clinical score values
from 1.5 to 5.5 (Fig. 1a–c). On the other hand, only pyrexia
and mild apathy were registered from day 4 to 7 dpi in
pestivirus-free-ASFV infected wild boars (Group B); neverthe-
less, two animals suddenly died at 8 dpi. On the contrary,
only animal number 4 presented pyrexia (40 °C - 40.7 °C)
and slight nasal secretions between 5 dpi and 8 dpi,
remaining clinically asymptomatic from then on until the end
of the experiment (Fig. 1a–c). Thus, statistical significant dif-
ferences (p < 0.05) in terms of clinical signs between both ex-
perimental groups were found from 4 dpi to 7 dpi (Fig. 1c).
Despite the clinical differences observed between both
groups, no statistical differences were found in the sur-
vival analysis. In this respect, the survival of CSFV-
ASFV infected animals (Group A) was equal to the
pestivirus-free-wild boars from Group B. Only animal 4
in Group B survived the ASFV infection until the end of
the trial (10 dpi).
Although animals 5 and 6 of Group B suddenly died,
several macroscopic lesions were observed after necropsy,
which consisted of splenomegaly, splenic haemorrhagic,
generalized lymphadenitis, moderate haemorrhagic enter-
itis, petechiae in the kidney and ascites. The surviving ani-
mal at the end of the study (animal 4 of Group B) had
only a few petechiae in the kidney.
CSFV RNA detection after ASFV infection
Wild boars from Group A maintained similar CSFV RNA
load during the whole trial even after ASFV infection. A
high and constant CSFV RNA load in serum and swabs was
found when examined by CSFV q-RT-PCR [39] (Fig. 2). A
similar CSFV RNA load was detected in the tonsil and lung
from these infected animals, with Ct values about 22–25
(data not shown). The samples analysed from Group B were
CSFV RNA negative (data not shown).
ASFV DNA detection
ASFV DNA was detected in all samples analysed from
both experimental groups. At 7 dpi, the animals from
Group A (CSFV-ASFV infected) were found viraemic
with a Ct value of around 17, corresponding with a high
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viral load in sera (Fig. 3a). In the case of ASFV-infected
animals from Group B, similar Ct values were detected
in two serum samples (animals 5 and 6). On the con-
trary, a lower DNA viral load (Ct value 24) was detected
in the serum of animal 4. The ASFV DNA viral load de-
tected in nasal and rectal swabs was comparable be-
tween both groups except for animal 4 (Group B), with a
lower Ct value. At 10 dpi, the ASFV DNA viral load de-
tected in the survivor (animal 4) considerably dimin-
ished with respect to day 7, with a Ct value of 26.25,
32.65 and 34.54 in sera, nasal and rectal swabs, respect-
ively. Finally, similar results to those previously found in
serum and swabs were obtained in tonsil, lung and
spleen tissues in both experimental groups (Fig. 3b).
Fig. 1 Rectal temperature and clinical score values after ASFV infection. a The individual rectal temperature values that were detected after the
ASFV strain infection. Temperatures greater than 40 °C were considered fevers. b The individual clinical score values that were detected after the
E75 strain infection. c The mean and standard deviation of the clinical score values recorded after ASFV infection. An asterisk indicates statistical
significance between the two groups from day 5 until day 7 (p < 0.05)
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Specific CSFV and ASFV antibodies detection
Sera from all the animals in Groups A and B were nega-
tive for the CSFV E2-specific antibodies and CSFV neu-
tralising antibodies during the trial. For ASFV-specific
antibody response, only the surviving animal of Group B
(animal 4) was positive at 10 dpi, with a blocking per-
centage of 72%. The rest of the animals from Group B
(animals 5 and 6) and from Group A remained negative
at all sampling times.
ELISA detection of serum soluble factors
TNF-α and IL-6 were not detected in any sample at 0
and at 7 days post-ASFV infection. In contrast, high
IFN-α levels were found only in the samples from Group
B after 7 days post-ASFV infection (Table 1), and signifi-
cant differences (p < 0.05) were observed between
Group A and B piglets at day 7 dpi. Within the B group,
the IFN-α values observed for pigs 5 and 6 were ap-
proximately 30% higher than that detected in pig 4
(Table 1). For IFN-γ, a variable response was detected in
both experimental groups after ASFV infection (7 dpi),
as two out of three animals were positive in Group A
and one out of three was positive in Group B (Table 1).
Additionally, IL-10 was detected only in Group B at 7
dpi. Finally, high levels of sCD163 were detected at 7 dpi
in both Groups A and B (Fig. 4). For animal 4 (Group B)
the level of sCD163 decreased to basal levels at 10 ASFV
dpi (under 80,000).
PBMC phenotype analysis after CSFV and ASFV infection
Before ASFV infection (0 dpi), the percentage of the T
CD4+ cell population was higher (p = 0.08) in the CSFV
PI animals (Group A, animals 2 and 3) than in the non-
infected animals (pestivirus-free wild boars 4 to 6 from
Group B). Further, the percentage of CD172a+ was
higher in the infected than in the non-infected animals
(Group B). Unfortunately, animals 5 and 6 (Group B)
died suddenly, and therefore, it was impossible to collect
PBMCs after ASFV infection. Thus, the comparative
study of the porcine surface markers expression included
samples only from animals numbered 2 to 4 at 7 dpi.
The results showed a marked effect on the CD4+ and
CD172a+ populations in animals from Group A (1 and
2) after ASFV infection (Table 2). On the one hand, the
percentage of T CD4+ cell populations drastically de-
creased from 15 to 17% to 3% (p = 0.10). On the other
hand, at the time of necropsy, the CSFV PI animals
(Group A) showed a 20% increase in the CD172a+ cell
population after ASFV infection compared to their pre-
infection status. Moreover, the percentage of CD172a+
cells in these animals 2 and 3 at 7 dpi was higher and
statistically different (p = 0.08) than in the non-infected
naive animals (wild boars from group B before ASFV in-
fection). In contrast, the surviving ASFV-infected animal
from Group B at 10 dpi (animal 4) presented around a
10% decrease in the CD172a+ compared to the samples
at day 0 (Table 2). In parallel, the forward versus scat-
tered dot-plot side representation (FSC/SSC) indicated a
high-complexity region that may correspond to im-
mature granulocytes in the samples from Group A
(data not shown).
Discussion
The ASF and CSF situation in Eastern Europe is of con-
cern due to the current epidemiological complexity [7,
24, 25]. In this sense, the role of wild boar populations
may be one of the main components in disease mainten-
ance in these geographic areas [7, 24].
In the present work, we studied some virological and
immunological parameters related to the innate and
adaptive immune response in CSFV PI animals after
ASFV infection, a virus that causes one of the most dev-
astating diseases in swine. Likewise, we assessed the sur-
vival and disease progression in animals with CSF PI
compared to those with ASFV infection. For this pur-
pose, CSFV-PI wild boars were inoculated with a viru-
lent ASFV strain. Finally, virological and immunological
parameters after ASFV infection in naive wild boars
were also assessed.
Even though the high infection rate of the Cat01 strain
of CSFV PI wild boars was in accordance with previous
studies, good health status was maintained before ASFV
infection [24, 28]. Interestingly, the animals infected with
a CSF persistent form (Group A) showed a progressive
acute haemorrhagic disease after ASFV infection. In
Group B, two pestivirus-free wild boars suddenly died
shortly after ASFV infection (5 and 6 dpi), accordingly
with previously published reports [44]. However, none of
the pestivirus-free-ASFV infected wild boars (Group B)
Fig. 2 Mean values and standard deviation values of the CSFV
Catalonia strain RNA detection in serum, nasal and rectal swabs at
different times before and after ASFV infection. CSFV Catalonia strain
RNA detection in serum, nasal and rectal swabs samples in CSFV PI
animals from Group A (numbers 1 to 3) at 5 days before ASFV
infection, and at 0 and 7 days post ASFV infection. A dotted bar
indicates the detection limit of the technique above 42 Ct
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Fig. 3 ASFV E75 strain DNA detection in serum, nasal and rectal swabs and in tissues samples at different times after ASFV infection. a ASFV DNA
detection in serum, nasal and rectal swabs samples in CSFV PI animals from Group A (numbers 1 to 3) and in pestivirus-free animals from Group
B (numbers 4 to 6) at 7 days post ASFV infection. b ASFV DNA detection in tonsil, lung and spleen samples in both experimental Groups A and B.
The detection limit of the technique was above 40 Ct
Table 1 Serum soluble factors detection at 7 days post ASFV infection
Experimental groups Animal
identifications
ELISA detection of serum soluble factors
IFN-α IFN-γ IL-10
CSFV-PI infected with ASFV E75 1 24 0 0
2a 0 66 0
3 40 915 0
Pestivirus Free- Infected with ASFV E75 4 122 0 39
5 193 0 17
6 184 213 149
apig number 2 was sampled at 6 ASFV dpi (before necropsy)
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developed the haemorrhagic clinical form of the disease.
Despite the different clinical pictures recorded between
both experimental groups, the survival rate after ASFV
infection was similar, suggesting that CSFV PI animals,
regardless of their immunosuppression state, are equally
susceptible towards ASFV infection as pestivirus-free an-
imals would be [24, 25].
Notably, the ASFV DNA load detected after infection
in sera, swabs and tissue samples was high and similar
for both groups, correlating with the ASF acute form
[17, 44]. In addition, the CSFV RNA load in CSFV-
ASFV-infected animals (Group A) remained unaltered
after ASFV infection during the trial [24, 42].
A recent report showed that vaccination against CSFV
could yield CSF progression in CSFV PI animals, al-
though signs of cyanosis or haemorrhage were not previ-
ously observed [42]. Considering this precedent, the
ASFV infection could be a trigger factor for the haemor-
rhagic disease progression in the CSFV PI wild boars. It
is worth highlighting the high variability in the infection
generated by ASFV in swine [37]. Although only three
animals per group were used in this study, our results
suggest that the CSFV subclinical infection may also pre-
dispose animals to ASF disease and aggravate its pro-
gression, considering that the three animals from Group
A showed cyanosis and severe haemorrhage in the skin.
In agreement with the high variability generated by
ASFV in swine, two of the pestivirus-free-ASFV infected
wild boars from Group B suddenly died and one of them
remained clinically asymptomatic until the end of the
experiment. Although clinical signs were almost un-
apparent, this animal remained ASFV positive in the
serum and excreted virus during the study. In addition,
it was the only animal able to seroconvert against ASFV
at 10 dpi. It is known that pigs that survive natural in-
fection usually develop antibodies against ASFV from 7
to 10 days post-infection which persist for a long period
of time [45]. Therefore, the detection of specific anti-
bodies against ASFV is very useful for the diagnosis of
inapparent forms of ASF [46]. Thus, despite the short
duration of the experiment, this animal would represent
an ASF subclinical case.
Fig. 4 sCD163 levels found before and after 7 days post ASFV infection in both experimental Groups A and B. The results are expressed as the
equivalent number of CD-163-transfected cells




0 days post-ASFV-infectiona End-point lifetime after ASFV infectiona
CD4+ CD8+ CD172a+ CD4+ CD8+ CD172a+
CSFV-PI infected with ASFV E75 2 17 17 43 3 11 76
3 15 14 63 3 21 73
Pestivirus Free- Infected with ASFV E75 4 7 16 30 11 26 19
5 8 17 27
6 7 20 32
aValues expressed in %
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It is known that ASFV activates monocytes/macro-
phages that secrete a wide range of mediators including
pro-inflammatory cytokines such as IL-6 and TNF-α
[47–49], which can trigger acute phase reactions, inflam-
mation, activation of endothelial cells and apoptosis.
Paradoxically, the absence of IL-6 and TNF- α was de-
tected in the sera from both experimentally infected
groups. On the other hand, it is also known that IL-10
inhibits a broad spectrum of immune responses, including
the suppression of T cell proliferation, cytokine production
and B cell responses [50–53]. Interestingly, all the ASFV-
infected wild boars from group B showed detectable IL-10
levels in sera, a finding previously described in the ASF dis-
ease [48, 54]. In contrast, despite the ASFV replication in
CSF-persistent animals, IL-10 levels in sera were not found,
as previously reported in CSF-persistent disease [25].
Notably, the sCD163 is an activation macrophage
marker that has been associated with acute ASF disease at
7 dpi [17]. Accordingly, high levels were found associated
with ASFV infection in both experimental groups, with
the highest values detected in the Group B animals that
suddenly died. Interestingly, low levels of sCD163 were
found in the survivor animal from Group B at 10 dpi, at
which time a lower DNA ASFV load was detected.
In parallel, we analysed the capacity of ASFV to gener-
ate IFN-γ response in both infected groups. Notably, sol-
uble IFN-γ was detected in some animals from both
experimental groups. This finding is supported by data
previously published in ASF-acute-infected domestic
pigs [55] and suggests the swine immune system capabil-
ity in CSFV PI animals to produce Type II IFN-γ against
the unrelated viral infection. Otherwise, in the case of
innate immune response against ASFV, as measured by
type I IFN-α in the serum, it is worth mentioning that
IFN-α was detected in all ASFV-infected animals from
Group B, mainly in the animals that suddenly died. In
this context, the IFN-α increase has been related to the
cytokine storm after ASF disease [16, 17, 56]. Remark-
ably, lower IFN-α levels were found in the surviving
ASFV-infected wild boar, correlating with its capability
to control the infection. Strikingly, once again, the IFN-
α response seemed to be impaired in CSFV PI animals,
even after infection with the ASFV virus, which induces
a potent effect on the innate immune system. The CSFV
PI animals remained IFN-α negative, a cornerstone in
the innate immune mechanisms; this fact might promote
the maintenance of a high and constant CSFV load, as
already described [28, 42]. Additionally, it may explain
the CSFV ability to generate the SIE phenomenon previ-
ously described in swine [28].
The flow cytometry analysis showed that the percentage
of CD8+ T cell populations were similar between both ex-
perimental groups before ASFV infection. Whereas, CD4+
T cell populations were increased in CSFV PI animals,
despite previously being in a state of immunosuppression
[24, 25]. However, the CD4+ T cell subset drastically de-
creased after ASFV infection, suggesting the incapacity to
induce an effective immune response to ASFV [44, 57].
These results are underpinned by the capacity to over-
come the disease in the ASFV survivor animal from
Group B, in which the T cell populations remained almost
within normal parameters. Finally, it is known that mye-
loid cells, granulocytes and monocyte/macrophages play a
relevant role in ASFV and CSFV pathogenesis in swine.
Considering this fact and in accordance with a previous
report, the percentage of CD172a+ cells found in the
PBMCs from CSFV PI animals increased by 20% over the
value found in naive wild boars [25]. It is also known that
the progression of CSFV infection induced a clear imbal-
ance in the proportion of blood cells towards enrichment
in the CD172a+ cells subset [36, 58]. This population,
which has been identified as immature granulocytes [36],
specifically 6D10+ cells, were the predominant cell popula-
tion in CSFV PI pigs [25]. Thus, in agreement with previ-
ous data, the 6D10+ cell profile can explain the increase in
the CD172a+ cells after ASFV infection, due to the constant
imbalance in the homeostasis in CSFV-ASFV infected wild
boars, thereby hampering the immune response against
ASFV. On the contrary, the lowering of CD172a+ cells in
ASFV-infected animal 4 correlates with the decrease in
macrophages described after ASFV infections [57, 59].
Conclusion
Overall, our findings showed the development of a cellular
homeostasis imbalance, and a type I Interferon blockade
after ASFV infection of CSFV PI animals, which may ex-
plain how CSFV persists in the infected host. On the other
hand, it should be noted that in terms of viral replication,
ASFV infection does not produce any interference with
CSFV replication, or vice versa. Despite the high DNA load
generated after the ASFV infection, in CSFV PI animals, the
CSFV RNA load remained high and unaltered during the
trial. Additionally, ASFV infection could be a trigger factor
for disease progression in the CSFV PI wild boars. Likewise,
our results also suggest that the subclinical CSFV infection
may be aggravating the ASF disease, considering that only
the three CSFV persistently infected animals developed clin-
ical haemorrhagic signs after ASFV infection. The survival
rate against ASFV in CSFV PI animals was equal to those
animals in the pestivirus-free ASFV-infected group; this fact
may mean that there are relevant implications for CSF con-
trol in endemic countries, because they suggest the high re-
sistance of these types of animals, even against a virus like
ASFV. Finally, considering the co-existence of the increasing
spread of ASF and the presence of CSF subclinical forms in
endemic countries for both diseases, the possibility of ASFV
and CSFV co-infection in swine cannot be ruled out and
needs to be studied in greater depth.
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